Bobby Brooke Herrera, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dengue | 5 | 2024 | 254 | 1.310 |
Why?
|
Viral Nonstructural Proteins | 3 | 2020 | 223 | 1.260 |
Why?
|
Dengue Virus | 3 | 2020 | 200 | 1.220 |
Why?
|
Metal Nanoparticles | 2 | 2022 | 396 | 1.210 |
Why?
|
HTLV-I Infections | 2 | 2024 | 103 | 1.060 |
Why?
|
Human T-lymphotropic virus 1 | 2 | 2024 | 142 | 1.040 |
Why?
|
Arenaviridae | 1 | 2024 | 5 | 0.950 |
Why?
|
Enzyme-Linked Immunospot Assay | 3 | 2018 | 123 | 0.910 |
Why?
|
RNA Viruses | 1 | 2024 | 110 | 0.850 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 608 | 0.540 |
Why?
|
Ebolavirus | 1 | 2018 | 251 | 0.510 |
Why?
|
Vaccines | 1 | 2024 | 832 | 0.500 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 584 | 0.490 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2018 | 420 | 0.430 |
Why?
|
Antibodies, Viral | 4 | 2020 | 3142 | 0.380 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10171 | 0.360 |
Why?
|
Gold | 2 | 2022 | 479 | 0.310 |
Why?
|
Antigens, Viral | 2 | 2021 | 980 | 0.280 |
Why?
|
Sensitivity and Specificity | 7 | 2024 | 14641 | 0.260 |
Why?
|
Shigella flexneri | 2 | 2016 | 119 | 0.240 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2024 | 32 | 0.240 |
Why?
|
Arboviruses | 1 | 2024 | 13 | 0.240 |
Why?
|
Arbovirus Infections | 1 | 2024 | 21 | 0.230 |
Why?
|
HTLV-I Antibodies | 1 | 2022 | 35 | 0.220 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3801 | 0.210 |
Why?
|
Deltaretrovirus | 1 | 2022 | 161 | 0.210 |
Why?
|
Brazil | 3 | 2024 | 1217 | 0.190 |
Why?
|
Immunologic Tests | 1 | 2022 | 103 | 0.190 |
Why?
|
Chikungunya virus | 1 | 2020 | 53 | 0.170 |
Why?
|
Exosomes | 1 | 2024 | 423 | 0.170 |
Why?
|
Adaptive Immunity | 1 | 2024 | 726 | 0.160 |
Why?
|
Congo | 1 | 2018 | 13 | 0.160 |
Why?
|
Africa, Western | 1 | 2018 | 159 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1765 | 0.140 |
Why?
|
RNA Helicases | 1 | 2018 | 146 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1075 | 0.140 |
Why?
|
Immunoassay | 1 | 2020 | 746 | 0.140 |
Why?
|
Senegal | 1 | 2017 | 256 | 0.140 |
Why?
|
Yersinia pseudotuberculosis | 1 | 2016 | 25 | 0.130 |
Why?
|
Cross Reactions | 1 | 2018 | 818 | 0.130 |
Why?
|
Seroepidemiologic Studies | 1 | 2017 | 394 | 0.130 |
Why?
|
Antigens, Bacterial | 2 | 2018 | 1155 | 0.120 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2015 | 93 | 0.120 |
Why?
|
Vimentin | 1 | 2016 | 255 | 0.120 |
Why?
|
Dysentery, Bacillary | 1 | 2015 | 74 | 0.120 |
Why?
|
Bacterial Adhesion | 1 | 2016 | 306 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 787 | 0.120 |
Why?
|
Nigeria | 1 | 2017 | 762 | 0.120 |
Why?
|
Salmonella typhimurium | 1 | 2016 | 344 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2723 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1020 | 0.100 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2015 | 407 | 0.100 |
Why?
|
Bacterial Toxins | 1 | 2018 | 931 | 0.100 |
Why?
|
Virulence Factors | 1 | 2016 | 511 | 0.100 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 452 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4353 | 0.100 |
Why?
|
Honduras | 2 | 2020 | 37 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4567 | 0.090 |
Why?
|
Interferon-gamma | 1 | 2018 | 3156 | 0.090 |
Why?
|
Protein Kinase C | 1 | 2014 | 1199 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1120 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2014 | 1342 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2836 | 0.080 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9160 | 0.070 |
Why?
|
Humans | 16 | 2024 | 758381 | 0.070 |
Why?
|
Malaria | 1 | 2017 | 1226 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4342 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2057 | 0.070 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4540 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5425 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 58808 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2895 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12951 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2014 | 3824 | 0.050 |
Why?
|
Venezuela | 1 | 2020 | 75 | 0.040 |
Why?
|
Colombia | 1 | 2020 | 276 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 973 | 0.040 |
Why?
|
Latin America | 1 | 2020 | 405 | 0.040 |
Why?
|
Aged | 4 | 2021 | 168217 | 0.040 |
Why?
|
Biostatistics | 1 | 2020 | 164 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2020 | 437 | 0.040 |
Why?
|
Serologic Tests | 1 | 2020 | 383 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 42058 | 0.040 |
Why?
|
Female | 5 | 2021 | 390316 | 0.040 |
Why?
|
Middle Aged | 4 | 2021 | 219560 | 0.040 |
Why?
|
Mice | 2 | 2022 | 81107 | 0.040 |
Why?
|
Adult | 4 | 2021 | 219916 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25953 | 0.030 |
Why?
|
Viral Envelope Proteins | 1 | 2020 | 638 | 0.030 |
Why?
|
Keratin-18 | 1 | 2016 | 38 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36054 | 0.030 |
Why?
|
Data Collection | 1 | 2024 | 3322 | 0.030 |
Why?
|
Animals | 3 | 2022 | 167777 | 0.030 |
Why?
|
Focal Adhesions | 1 | 2014 | 114 | 0.030 |
Why?
|
Shigella | 1 | 2014 | 69 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 197 | 0.030 |
Why?
|
India | 1 | 2020 | 2329 | 0.030 |
Why?
|
Male | 4 | 2021 | 358742 | 0.030 |
Why?
|
Protein Binding | 2 | 2016 | 9312 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2014 | 401 | 0.030 |
Why?
|
Child | 2 | 2020 | 79813 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 87888 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2014 | 491 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3563 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2014 | 929 | 0.020 |
Why?
|
Cell Line | 2 | 2016 | 15594 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1165 | 0.020 |
Why?
|
Public Health | 1 | 2024 | 2658 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4549 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17275 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1963 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7338 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 80170 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3096 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5031 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5779 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1444 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3433 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4258 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2014 | 2695 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13447 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4341 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22006 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17617 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10417 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29558 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41252 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54136 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23341 | 0.010 |
Why?
|